Mustang Bio

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$4.05-$76
Market Cap
$7.2M
Shares Short
353,454

Financials

See more
Revenue (12 Mos)
-$50,000
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$66.50

News

See more

Yahoo Finance • last year

Mustang Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

Yahoo Finance • last year

Mustang Bio Announces MB-106 CD20-Targeted CAR-T Data Selected for Presentation at 65th American Society of Hematology (ASH) Annual Meeting

Yahoo Finance • last year

Mustang Bio Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Yahoo Finance • last year

Mustang Bio Announces FDA Acceptance of IND Application for MB-109, a Novel Combination of MB-101 (IL13Rα2‐targeted CAR-T cell therapy) and MB-108 (HSV-1 oncolytic virus), for the Treatment of Recurrent Glioblastoma and High-Grade Astrocytoma

About

CEO
Dr. Manuel Litchman M.D.
CFO
Dr. Manuel Litchman M.D.
Address
377 Plantation Street, Worcester, MA, United States, 01605
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
80